ArticleAnnals of medicine and surgery (2012)2022
Antimicrobial use and resistance in Democratic Republic of Congo: Implications and recommendations; A mini review.
Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Governance of antimicrobial resistance in Central Africa (2015-2025): a systematic review of policies, One Health coordination and funding.JAC-antimicrobial resistance · 2026Review
- Pediatric Bloodstream Infections in Eastern Democratic Republic of the Congo: Epidemiology, Antimicrobial Resistance Patterns, and Predictors of Mortality.Infection and drug resistance · 2026Article
- Antimicrobial resistance of bacteria isolated in a resource-limited region: the experience of the North Kivu Provincial Reference Laboratory in the Democratic Republic of the Congo.Frontiers in medicine · 2026Article
- Bacteriological profile and antimicrobial resistance in sepsis cases in intensive care units in Lubumbashi: challenges and perspectives.Annals of clinical microbiology and antimicrobials · 2025Article
- Antimicrobial resistance in a protracted war setting: a review of the literature from Palestine.mSystems · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance is a public health problem in the Democratic Republic of Congo and it occurs when pathogens (bacteria, viruses and parasites) no longer respond to antimicrobial drugs. So, their treatment becomes ineffective and complex increasing the risk the spread of infectious and opportunistic diseases and producing serious forms of these infections leading to a high number of deaths. It is important to put in place effective methods and materials for the prevention and treatment of infections resistant to antimicrobial drugs, to provide improved access to quality antimicrobials and to reduce the number of treatment failures. Increasing levels of resistance have significant economic consequences and third-line treatments become much more expensive than first- and second-line treatments. As antimicrobial resistance is a complex health problem that requires a coordinated multisector approach, it is important to intensify innovation in operational research and the development of new antimicrobial drugs. Surveillance remains a valuable tool in the fight against antimicrobial resistance in the Democratic Republic of Congo, as it helps to detect resistant infections and allows corrective decisions to be made, this surveillance guides policy recommendations and the monitoring of use and treatment and abuse of antibiotics. Our study aimed to show the importance of establishment of national plans for the fight against antimicrobial resistance by installing laboratories and monitoring sites in order to reduce the risk and rate of deaths due to antimicrobial resistance in the Demographic republic of Congo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.